Efficacy and safety of repeated samarium-153 lexidronam treatment in a patient with prostate cancer and metastatic bone pain.

Menda, Y; Bushnell, D L; Williams, R D; Miller, S; Thomas, M O

Menda, Y; Bushnell, D L; Williams, R D; Miller, S; Thomas, M O.

Affiliation

Menda Y; Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City 52242, USA.

Clin Nucl Med ; 25(9): 698-700, 2000 Sep.

Article in En | MEDLINE | ID: mdl-10983757

Subject(s)

Analgesics, Non-Narcotic/therapeutic use; Bone Neoplasms/pathology; Organometallic Compounds/therapeutic use; Organophosphorus Compounds/therapeutic use; Pain, Intractable/etiology; Prostatic Neoplasms/radiotherapy; Radiopharmaceuticals/therapeutic use; Bone Neoplasms/complications; Humans; Leukocyte Count; Male; Middle Aged; Pain Measurement; Pain, Intractable/psychology; Platelet Count; Prostatic Neoplasms/pathology; Quality of Life

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Organometallic Compounds / Organophosphorus Compounds / Pain, Intractable / Prostatic Neoplasms / Bone Neoplasms / Analgesics, Non-Narcotic / Radiopharmaceuticals Limits: Humans / Male / Middle aged Language: En Journal: Clin Nucl Med Year: 2000 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links